Fueled by creativity, developing
advanced genetic therapies.

A quest,
guided by compassion,
to halt degenerative diseases
in their tracks.

Ongoing collaboration with
world renowned scientists
at leading institutions

 

American Gene Technologies International’s CEO, Jeff Galvin,
recently presented at HIMSS Precisions Medicine Summit June 13 in Boston.

American Gene Technologies International’s CEO, Jeff Galvin,
recently presented at BIO International Convention June 19 in San Diego.

American Gene Technologies International’s CEO,
Jeff Galvin, recently presented at NobleCon13.

Overview

American Gene Technologies™ International (AGT) is a leader in the development of advanced genetic technologies to cure major human diseases such as cancer, metabolic disorders and infectious diseases. AGT is demonstrating the viability of a new wave of medicine with the promise of improving and extending human life and ending the suffering caused by formerly incurable diseases. In collaboration with globally recognized scientists with decades of disease research at leading institutions and partnerships with leading manufacturers in the cell and gene therapy arena, AGT is accelerating the delivery of treatments to global patient populations.

More About American Gene Technologies

Rapid Drug Development

Thousands of lentiviral vectors have been developed, tested and banked to make the drug development process more efficient.

Research Collaborators

World-class researchers partner with American Gene Technologies to design drugs using gene therapies within our lentiviral vectors.

Genetic Technologies

Our lentiviral vectors represent the latest advance in pharmaceuticals, and can be used to target a wide variety of diseases and conditions.

Leading Scientists

Internationally recognized scientists supporting roadmaps to drug development to combat multiple diseases and conditions.

© Copyright 2017 - American Gene Technologies International Inc.
X

Send this to a friend